Developer docs
API playgroundTry for free, no card

Search company profiles

Posos

Full company profile

uuid0000yzn

Namestring
Posos
Legal namestring
POSOS SAS
Websiteurl
posos.co
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Posos is a French medtech company headquartered in Amiens that operates a CE Class IIb certified clinical decision support platform designed to optimize medication prescribing for healthcare professionals across the patient journey. The platform combines a proprietary medical knowledge graph, hybrid natural language processing (NER/L, ML), computer vision for prescription scanning, and a multilingual, HAS-agrément drug database built from 220+ official sources and 100,000+ medical documents. Posos positions itself as the only certified plug-and-play software infrastructure that takes raw patient data (text, voice, scanned/PDF prescriptions) and produces normalized SNOMED-CT / FHIR / ICD-10/11 structured outputs and personalized prescription recommendations via GraphQL, FHIR, and CDS Hooks APIs.

The company monetizes through four streams: a freemium individual practitioner subscription (free basic tier, paid premium with 3-month trial, billed annually via Stripe), B2B API licensing to medical software editors who embed Posos into their EHR/LAP solutions (quote-based, multi-year), enterprise contracts with hospitals and healthcare establishments (quote-based, multi-year, including onboarding and training), and professional services. Go-to-market combines API-first OEM embedding (primary), direct enterprise field sales to hospitals, self-serve B2C via iOS/Android apps, channel partnerships with pharmacy networks and telehealth platforms, and event-driven presence at French healthcare conferences (SantExpo, SFAR).

Posos reports deployment at 300+ healthcare establishments and 90,000+ healthcare professionals across France, Belgium, and Luxembourg, via 15+ medical software editor partners including Equasens, Corilus, Bow Medical, InterSystems, Dedalus, Softway Medical, Tessan, Evolucare, and Orisha. The company has raised approximately €19.8M in cumulative funding (2019 seed, 2022 Series A, 2025 round) from investors including AG2R La Mondiale, Anaxago, Nord France Amorçage, Sofiouest, and Caisse des Dépôts. Notable strategic positions include a 2026 integration into the Corti Agentic Framework and a roadmap entry into personalized care plan generation.

Short descriptiontext

Posos is a French medtech company that operates a CE Class IIb certified AI platform for medication prescription decision support, serving medical software editors, hospitals, pharmacies, and individual practitioners across France, Belgium, and Luxembourg via APIs, embedded modules, and a freemium SaaS.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support, prescription safety software, drug knowledge database, medical AI APIs, healthcare interoperability
Product category
Clinical Decision Support Software
Social media profiles1 record
GTM motion6 records

Each record includes

Type, Description, Source

Revenue model4 records
1Freemium + Premium Subscription (B2C)
TypeFreemium
Description

Basic "Offre basique" provided free of charge; "Offre premium" paid subscription for advanced features (DDI Predictor cytochromatic interactions, anticholinergic load, renal/hepatic dosage, equivalences across 8 therapeutic classes, scan d'ordonnances). 3-month free trial of premium, then annual subscription paid by credit card via Stripe. Auto-renewing period-based contract (any started period due in full).

posos.co
2B2B API & Software Licensing (Éditeurs de logiciels)
TypeLicensing Royalties
Description

Recurring B2B licensing of CE IIb certified APIs (transcription, risk analysis, medication database) to medical software editors who embed Posos into their EHR/LAP solutions. Custom quote-based pricing ("Sur devis") with automatic updates and personalized onboarding.

posos.co
3Enterprise Hospital Contracts
TypeSubscription Recurring
Description

Custom-tailored ("Sur devis") annual enterprise contracts for healthcare establishments (hôpitaux, cliniques, EHPADs) covering three modules: (1) productivity augmentation through automatic retranscription, (2) therapeutic decision support, (3) complete medication reconciliation — typically integrated with the establishment's DPI/GAM.

posos.co
4Professional Services & Training
TypeProfessional Services
Description

Included with enterprise contracts: "Formation de vos personnels soignants à l'utilisation et au pilotage de la solution" — onboarding and training services for hospital teams, plus reactive customer support including pharmacists for technical and clinical questions.

posos.co
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details4 tiers
1Basique (free): basic interaction/contra-indication analysis, alternatives, bibliographic search
ModelFreemiumBilling cadenceAnnual
Notes

Free forever. Included: analysis of interactions and contraindications, therapeutic alternatives, bibliographic search engine.

posos.co
2Premium (individual): advanced contextual risk analysis, DDI Predictor, anticholinergic load, renal/hepatic dosage, photo-scan prescription transcription
ModelSubscriptionBilling cadenceAnnual
Notes

3-month free trial of premium, then annual subscription paid by credit card. Adds dosage adaptation to patient profile, origin of adverse effects, cytochrome interactions (DDI Predictor), anticholinergic load, dose equivalences across 8 therapeutic classes (vs. 6 in basic), automatic prescription scanning, tablet crushing info, renal/hepatic dosing, custom modules.

posos.co
3Établissement de Santé (hospital): full medication reconciliation, prescription decision support, productivity modules
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based ("Sur devis"). Includes automatic retranscription, therapeutic decision support, complete conciliation médicamenteuse integrated with DPI/GAM. "Mises à jour automatiques. Formation personnalisée gratuite." Includes onboarding/training.

posos.co
4Éditeurs de logiciels (API licensing): transcription API, risk analysis API, medication database API, custom integrations
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based ("Sur devis"). CE IIb certified APIs in FHIR format. Includes automatic updates and personalized free training.

posos.co
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Posos provides a CE IIb certified, ISO 13485 compliant AI medical platform that combines a drug knowledge graph, hybrid NLP and Computer Vision APIs for prescription transcription and clinical data structuring, and contextualized drug risk analysis. The platform is sold as a B2B API suite (FHIR, CDS Hooks, GraphQL) to medical software editors and as an enterprise solution to hospitals, with a freemium B2C mobile app for individual practitioners.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Posos offers a single, unified, CE class IIb-certified AI platform for medical prescription that combines an interconnected drug knowledge graph, hybrid NLP/CV structuring APIs, intelligent prescription transcription, contextualized drug risk analysis, and plug-and-play agents for partner software editors. The platform is composed of: (1) the Posos Drug Database (base de données médicamenteuse), the AI-built, HAS-approved multilingual structured drug reference; (2) the Intelligent Prescription Transcription module ("Scan & Go" / e-scan d'ordonnances / IA de standardisation SNOMED) for OCR and structuring of paper/PDF/voice prescriptions into SNOMED-CT/FHIR/ICD-10/11 data; (3) the Drug Risk Analysis module (Analyse des risques iatrogènes) for personalized interaction, contraindication, dosage and therapeutic-alternative recommendations; (4) Posos APIs (GraphQL/FHIR/CDS Hooks) for medical software editors and agentic AI developers; (5) the Conciliation médicamenteuse (medication reconciliation) module for hospital admissions; (6) the Bilans de médication / Entretiens pharmaceutiques solutions for retail pharmacy; (7) Mobile apps (iOS/Android) for individual practitioners. The platform is designed for two integration modes — APIs for teams building their own AI agents, and ready-to-deploy widgets (Prêt à l'emploi) for faster time-to-market. Certified ISO 13485, CE IIb, HDS-hosted, with French/Belgian/Luxembourg coverage and FDA-readiness.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership22 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-19
Description

Semble (UK-based medical software leader) confirmed its commitment to the French market and obtained Ségur Numérique vague 1 and LAP HAS v2 certifications with Posos — partnership enables Semble's compliance in France.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-19
Description

Okeiro (precision medicine platform for transplant and chronic kidney disease patients) integrated Posos' AI-assisted prescription technology to secure and facilitate the medication journey of transplant and CKD patients.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-19
Description

Posos joined the Corti Agentic Framework as an Expert on medications and prescription assistance, announced at SantExpo 2026. Posos is one of the first Experts integrated into Corti's multi-agent platform launched February 2026 — any AI agent built on Corti can now rely on Posos' medication data and CE IIb certified prescription algorithms.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-22
Description

NEHS Digital and Posos combine forces to offer optimized time management for anesthesiologists and emergency physicians — interview with Jean-Louis Baudet (NEHS Digital) and Emmanuel Bilbault (Posos) on the partnership.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-22
Description

Evolucare and Posos concluded a partnership to simplify the work of anesthesiologists — Posos e-scan and prescription support integrated into Evolucare's anesthesia software suite.

6Groupe Equasens
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-09-22
Description

Le Groupe Equasens and Posos partner to transform pharmacy dispensing with innovative AI — also reported by MarketScreener on 2024-11-21 as a 'strategic partnership in AI'. Equasens is one of France's leading pharmacy software groups.

posos.co
Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-09-22
Description

Corilus chose Posos to provide new-generation clinical assistance to prescribers in Belgium and France. Corilus integrates Posos into CareConnect and Softalmo: 'Avec Posos, nous intégrons une assistance clinique de référence au cœur de CareConnect et de Softalmo.' Represents a new standard of prescription in Corilus products.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-22
Description

Giropharm partnered with Posos to support its member pharmacists in carrying out their new clinical missions (entretiens pharmaceutiques, bilans partagés de médication) at the pharmacy counter.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-09-18
Description

Strategic expansion announced at SFAR 2025: Bow Medical deploys Posos' "Scan & Go" intelligent prescription re-entry module across its entire product range, including the Diane Consult online anesthesia consultation solution. The AI module automatically recognizes and transcribes patient treatments from photographed or scanned prescriptions, eliminating up to 1.5 hours of manual data entry per day. The integration covers 450+ healthcare facilities and potentially impacts 5+ million annual anesthesia consultations, marking a step toward AI-augmented medical practice in anesthesia.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-12
Description

Posos and Arche MC2 (major editor of software for social, medico-social, and healthcare sectors) automate prescription entry in HAD (Hospitalisation À Domicile) — integrating Posos' e-scan prescription technology directly into Arche MC2's AtHome software, the reference solution for HAD. Marks a turning point in HAD care processes.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-05-21
Description

Orisha Socialcare integrates Posos' e-scan prescription module into NETSoins and NETVie to strengthen the security of treatments in EHPADs and specialized medical establishments (MAS, FAM). Originally announced May 2025.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-02-04
Description

Reinforced technological alliance to accelerate and secure AI-assisted drug prescription worldwide. Posos integrates with InterSystems TrakCare (used at Centre Hospitalier de la Côte Basque) — combining Posos' clinical AI APIs with InterSystems' global EHR platform to enable secure AI-driven prescribing across international markets.

Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2025-02-01
Description

GTM/content partnership with Ouest-France (major French regional daily newspaper) to launch the Ouest-France Santé health thematic channel. Posos powers the medication glossary, pathologies, and content for Ouest-France Santé readers — providing verified medical information to the general public.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-01
Description

Posos and Mediprix partnership serving the clinical pharmacist — supports Mediprix-affiliated pharmacists in their new clinical missions via Posos platform.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-09-22
Description

Tessan (télémédecine) integrated Posos into its medical software to equip its doctors with simple, reliable, and compliant prescription tools. Quote from Jordan Cohen, CEO Tessan, featured on the Posos homepage. Tessan joins the Posos partner logo wall.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-05-01
Description

Qare (major French teleconsultation platform) proposed innovative and personalized teleconsultation by partnering with Posos for prescription assistance for physicians.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-01
Description

Posos and Viatris pursue their collaboration around a new shared medication reconciliation (bilan partagé de médication) solution to free the pharmacist from administrative load and dedicate more time to patient relationships.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-04-01
Description

Posos and Rofim partnered to offer a complete and innovative solution to French Cancer Treatment Centers (CLCC — Centres de Lutte Contre le Cancer) to improve diagnosis and patient care management in oncology.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-02-01
Description

Posos launched its medication reconciliation (bilan de médication) solution and partnered with Alphega Pharmacie to develop new patient services in retail pharmacies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-01
Description

MHComm and Posos formed a strategic partnership — major advance for the digitization of prescriptions in HAD (hospital-at-home).

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-11-01
Description

Softway Medical integrated Posos into its Hopital Manager hospital software — enabling prescription safety features for Softway's hospital customers in France.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2021-05-01
Description

SantExpo 2021 — A first in prescription assistance in hospitals with Dedalus and Posos. Dedalus is one of Europe's largest hospital software vendors; Posos is embedded in their hospital EHR suites.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Wolters Kluwer's Clinical Drug Information division offers Lexicomp and Medi-Span drug databases used by hospitals and EHRs for drug interaction, dosing, and clinical decision support. Direct peer to Posos' drug database and risk analysis API; larger and globally established with deeper hospital penetration.

TypeDirect peer
Description

FDB (owned by Hearst) provides drug databases (FDB MedKnowledge) and clinical decision support embedded in major US EHRs. Direct competitor in the structured drug knowledge / API-for-software-editors space; primarily US-focused but increasingly global.

TypeDirect peer
Description

DrFirst offers medication management, e-prescribing, drug interaction checking, and clinical workflow APIs used by hospitals, EHRs, and pharmacies. Comparable to Posos' prescription safety and risk analysis APIs; US-based with similar B2B-to-software-editor GTM.

4Elsevier Clinical Solutions (ClinicalKey/Gold Standard)
TypeBroad incumbent
Description

Elsevier's Clinical Solutions includes drug databases (Gold Standard), ClinicalPath decision support, and ClinicalKey reference platform embedded across global hospital systems. Broad incumbent with overlapping drug database capabilities but a much wider portfolio beyond prescription safety.

5Oracle Health (Cerner Multum)
TypeBroad incumbent
Description

Oracle Health (formerly Cerner) bundles the Multum drug database and clinical decision support within its dominant EHR installed base. Massive global incumbent; competes with Posos at the hospital EHR layer and increasingly partners/competes via its own drug database.

TypeDirect peer
Description

Corti builds the Agentic Framework for clinical AI workflows, launched February 2026, into which Posos was integrated as a drug/prescription Expert. Comparable AI-platform-for-clinicians offering with overlapping customer base (hospitals, telehealth), though focused on ambient conversation/intake rather than drug safety.

TypeEmerging player
Description

Suki AI offers an AI voice assistant for clinicians that automates documentation, coding, and point-of-care queries including drug information. Emerging AI assistant for clinicians — partial overlap with Posos' individual practitioner product, though focused on ambient documentation rather than drug safety.

TypeEmerging player
Description

Nabla is an AI ambient scribe and clinical assistant for physicians, expanding into broader clinical decision support. Partial overlap with Posos' individual clinician product; both target AI-augmented prescribing workflows but Nabla leads with documentation.

TypeEmerging player
Description

Abridge is a medical conversation AI platform that structures patient-clinician dialogue into clinical notes, codes, and orders. Comparable AI-for-clinicians GTM with hospital system integrations; potential partner or competitor as it expands into order entry and prescription workflows.

TypeEmerging player
Description

Infermedica builds AI-powered symptom checking, triage, and preliminary diagnosis tools used by insurers, telehealth, and hospital systems. Adjacent clinical decision support category with API-first delivery; Europe-based (Poland) and comparable scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration26 records

Each record includes

Title, Type, Description, Source

AI capability13 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Posos

Clinical Decision Support Softwareposos.co

Posos is a French medtech company that operates a CE Class IIb certified AI platform for medication prescription decision support, serving medical software editors, hospitals, pharmacies, and individual practitioners across France, Belgium, and Luxembourg via APIs, embedded modules, and a freemium SaaS.

What Posos does

Posos is a French medtech company headquartered in Amiens that operates a CE Class IIb certified clinical decision support platform designed to optimize medication prescribing for healthcare professionals across the patient journey. The platform combines a proprietary medical knowledge graph, hybrid natural language processing (NER/L, ML), computer vision for prescription scanning, and a multilingual, HAS-agrément drug database built from 220+ official sources and 100,000+ medical documents. Posos positions itself as the only certified plug-and-play software infrastructure that takes raw patient data (text, voice, scanned/PDF prescriptions) and produces normalized SNOMED-CT / FHIR / ICD-10/11 structured outputs and personalized prescription recommendations via GraphQL, FHIR, and CDS Hooks APIs.

The company monetizes through four streams: a freemium individual practitioner subscription (free basic tier, paid premium with 3-month trial, billed annually via Stripe), B2B API licensing to medical software editors who embed Posos into their EHR/LAP solutions (quote-based, multi-year), enterprise contracts with hospitals and healthcare establishments (quote-based, multi-year, including onboarding and training), and professional services. Go-to-market combines API-first OEM embedding (primary), direct enterprise field sales to hospitals, self-serve B2C via iOS/Android apps, channel partnerships with pharmacy networks and telehealth platforms, and event-driven presence at French healthcare conferences (SantExpo, SFAR).

Posos reports deployment at 300+ healthcare establishments and 90,000+ healthcare professionals across France, Belgium, and Luxembourg, via 15+ medical software editor partners including Equasens, Corilus, Bow Medical, InterSystems, Dedalus, Softway Medical, Tessan, Evolucare, and Orisha. The company has raised approximately €19.8M in cumulative funding (2019 seed, 2022 Series A, 2025 round) from investors including AG2R La Mondiale, Anaxago, Nord France Amorçage, Sofiouest, and Caisse des Dépôts. Notable strategic positions include a 2026 integration into the Corti Agentic Framework and a roadmap entry into personalized care plan generation.

Posos firmographics

Firmographics
Name
Posos
Legal name
POSOS SAS
Website
https://posos.co
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
Posos is a French medtech company that operates a CE Class IIb certified AI platform for medication prescription decision support, serving medical software editors, hospitals, pharmacies, and individual practitioners across France, Belgium, and Luxembourg via APIs, embedded modules, and a freemium SaaS.
Ownership category
akta.pro rank

Where Posos is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Posos business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Freemium + Premium Subscription (B2C): Basic "Offre basique" provided free of charge; "Offre premium" paid subscription for advanced features (DDI Predictor cytochromatic interactions, anticholinergic load, renal/hepatic dosage, equivalences across 8 therapeutic classes, scan d'ordonnances). 3-month free trial of premium, then annual subscription paid by credit card via Stripe. Auto-renewing period-based contract (any started period due in full).
  2. B2B API & Software Licensing (Éditeurs de logiciels): Recurring B2B licensing of CE IIb certified APIs (transcription, risk analysis, medication database) to medical software editors who embed Posos into their EHR/LAP solutions. Custom quote-based pricing ("Sur devis") with automatic updates and personalized onboarding.
  3. Enterprise Hospital Contracts: Custom-tailored ("Sur devis") annual enterprise contracts for healthcare establishments (hôpitaux, cliniques, EHPADs) covering three modules: (1) productivity augmentation through automatic retranscription, (2) therapeutic decision support, (3) complete medication reconciliation — typically integrated with the establishment's DPI/GAM.
  4. Professional Services & Training: Included with enterprise contracts: "Formation de vos personnels soignants à l'utilisation et au pilotage de la solution" — onboarding and training services for hospital teams, plus reactive customer support including pharmacists for technical and clinical questions.

Pricing tiers

ModelBillingPrice
FreemiumAnnualBasique (free): basic interaction/contra-indication analysis, alternatives, bibliographic search
SubscriptionAnnualPremium (individual): advanced contextual risk analysis, DDI Predictor, anticholinergic load, renal/hepatic dosage, photo-scan prescription transcription
SubscriptionMulti-year contractÉtablissement de Santé (hospital): full medication reconciliation, prescription decision support, productivity modules
OtherMulti-year contractÉditeurs de logiciels (API licensing): transcription API, risk analysis API, medication database API, custom integrations

Go-to-market motion6 records

Distribution channels1 record

Marketing channels8 records

Posos product offering

Product offering

Core offering

Posos provides a CE IIb certified, ISO 13485 compliant AI medical platform that combines a drug knowledge graph, hybrid NLP and Computer Vision APIs for prescription transcription and clinical data structuring, and contextualized drug risk analysis. The platform is sold as a B2B API suite (FHIR, CDS Hooks, GraphQL) to medical software editors and as an enterprise solution to hospitals, with a freemium B2C mobile app for individual practitioners.

Product overview

Posos offers a single, unified, CE class IIb-certified AI platform for medical prescription that combines an interconnected drug knowledge graph, hybrid NLP/CV structuring APIs, intelligent prescription transcription, contextualized drug risk analysis, and plug-and-play agents for partner software editors. The platform is composed of: (1) the Posos Drug Database (base de données médicamenteuse), the AI-built, HAS-approved multilingual structured drug reference; (2) the Intelligent Prescription Transcription module ("Scan & Go" / e-scan d'ordonnances / IA de standardisation SNOMED) for OCR and structuring of paper/PDF/voice prescriptions into SNOMED-CT/FHIR/ICD-10/11 data; (3) the Drug Risk Analysis module (Analyse des risques iatrogènes) for personalized interaction, contraindication, dosage and therapeutic-alternative recommendations; (4) Posos APIs (GraphQL/FHIR/CDS Hooks) for medical software editors and agentic AI developers; (5) the Conciliation médicamenteuse (medication reconciliation) module for hospital admissions; (6) the Bilans de médication / Entretiens pharmaceutiques solutions for retail pharmacy; (7) Mobile apps (iOS/Android) for individual practitioners. The platform is designed for two integration modes — APIs for teams building their own AI agents, and ready-to-deploy widgets (Prêt à l'emploi) for faster time-to-market. Certified ISO 13485, CE IIb, HDS-hosted, with French/Belgian/Luxembourg coverage and FDA-readiness.

Differentiator

Problem solved

Functional benefit

Companies that use Posos

Customer profile

Named customers11 records

Segments8 records

Ideal customer profiles3 records

Posos technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration26 records

AI capability13 records

Feature8 records

Posos partnerships and signals

Strategic signal

Partnerships

22 partnerships are on record, tiered core and flagship.

  • SemblecoreStrategic or Co-development Partner · 19 May 2026Semble (UK-based medical software leader) confirmed its commitment to the French market and obtained Ségur Numérique vague 1 and LAP HAS v2 certifications with Posos — partnership enables Semble's compliance in France.
  • OkeirocoreStrategic or Co-development Partner · 19 May 2026Okeiro (precision medicine platform for transplant and chronic kidney disease patients) integrated Posos' AI-assisted prescription technology to secure and facilitate the medication journey of transplant and CKD patients.
  • CortiflagshipStrategic or Co-development Partner · 19 May 2026Posos joined the Corti Agentic Framework as an Expert on medications and prescription assistance, announced at SantExpo 2026. Posos is one of the first Experts integrated into Corti's multi-agent platform launched February 2026 — any AI agent built on Corti can now rely on Posos' medication data and CE IIb certified prescription algorithms.
  • NEHS DigitalcoreTechnology or Integration · 22 September 2025NEHS Digital and Posos combine forces to offer optimized time management for anesthesiologists and emergency physicians — interview with Jean-Louis Baudet (NEHS Digital) and Emmanuel Bilbault (Posos) on the partnership.
  • EvolucarecoreTechnology or Integration · 22 September 2025Evolucare and Posos concluded a partnership to simplify the work of anesthesiologists — Posos e-scan and prescription support integrated into Evolucare's anesthesia software suite.
  • Groupe EquasensflagshipStrategic or Co-development Partner · 22 September 2025Le Groupe Equasens and Posos partner to transform pharmacy dispensing with innovative AI — also reported by MarketScreener on 2024-11-21 as a 'strategic partnership in AI'. Equasens is one of France's leading pharmacy software groups.
  • CorilusflagshipOEM/ Whitelabel/ Licensing Partner · 22 September 2025Corilus chose Posos to provide new-generation clinical assistance to prescribers in Belgium and France. Corilus integrates Posos into CareConnect and Softalmo: 'Avec Posos, nous intégrons une assistance clinique de référence au cœur de CareConnect et de Softalmo.' Represents a new standard of prescription in Corilus products.
  • GiropharmcoreChannel Partner/ Reseller/ Distributor · 22 September 2025Giropharm partnered with Posos to support its member pharmacists in carrying out their new clinical missions (entretiens pharmaceutiques, bilans partagés de médication) at the pharmacy counter.
  • Bow MedicalflagshipTechnology or Integration · 18 September 2025Strategic expansion announced at SFAR 2025: Bow Medical deploys Posos' "Scan & Go" intelligent prescription re-entry module across its entire product range, including the Diane Consult online anesthesia consultation solution. The AI module automatically recognizes and transcribes patient treatments from photographed or scanned prescriptions, eliminating up to 1.5 hours of manual data entry per day. The integration covers 450+ healthcare facilities and potentially impacts 5+ million annual anesthesia consultations, marking a step toward AI-augmented medical practice in anesthesia.
  • Arche MC2coreStrategic or Co-development Partner · 12 June 2025Posos and Arche MC2 (major editor of software for social, medico-social, and healthcare sectors) automate prescription entry in HAD (Hospitalisation À Domicile) — integrating Posos' e-scan prescription technology directly into Arche MC2's AtHome software, the reference solution for HAD. Marks a turning point in HAD care processes.
  • Orisha Socialcare (ex Teranga Software)coreTechnology or Integration · 21 May 2025Orisha Socialcare integrates Posos' e-scan prescription module into NETSoins and NETVie to strengthen the security of treatments in EHPADs and specialized medical establishments (MAS, FAM). Originally announced May 2025.
  • InterSystemsflagshipStrategic or Co-development Partner · 4 February 2025Reinforced technological alliance to accelerate and secure AI-assisted drug prescription worldwide. Posos integrates with InterSystems TrakCare (used at Centre Hospitalier de la Côte Basque) — combining Posos' clinical AI APIs with InterSystems' global EHR platform to enable secure AI-driven prescribing across international markets.
  • Ouest-FranceflagshipGTM or Marketing Partner · 1 February 2025GTM/content partnership with Ouest-France (major French regional daily newspaper) to launch the Ouest-France Santé health thematic channel. Posos powers the medication glossary, pathologies, and content for Ouest-France Santé readers — providing verified medical information to the general public.
  • MediprixcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Posos and Mediprix partnership serving the clinical pharmacist — supports Mediprix-affiliated pharmacists in their new clinical missions via Posos platform.
  • TessancoreOEM/ Whitelabel/ Licensing Partner · 22 September 2024Tessan (télémédecine) integrated Posos into its medical software to equip its doctors with simple, reliable, and compliant prescription tools. Quote from Jordan Cohen, CEO Tessan, featured on the Posos homepage. Tessan joins the Posos partner logo wall.
  • QarecoreTechnology or Integration · 1 May 2024Qare (major French teleconsultation platform) proposed innovative and personalized teleconsultation by partnering with Posos for prescription assistance for physicians.
  • ViatriscoreStrategic or Co-development Partner · 1 May 2024Posos and Viatris pursue their collaboration around a new shared medication reconciliation (bilan partagé de médication) solution to free the pharmacist from administrative load and dedicate more time to patient relationships.
  • RofimcoreTechnology or Integration · 1 April 2024Posos and Rofim partnered to offer a complete and innovative solution to French Cancer Treatment Centers (CLCC — Centres de Lutte Contre le Cancer) to improve diagnosis and patient care management in oncology.
  • Alphega PharmaciecoreChannel Partner/ Reseller/ Distributor · 1 February 2024Posos launched its medication reconciliation (bilan de médication) solution and partnered with Alphega Pharmacie to develop new patient services in retail pharmacies.
  • MHCommcoreStrategic or Co-development Partner · 1 October 2023MHComm and Posos formed a strategic partnership — major advance for the digitization of prescriptions in HAD (hospital-at-home).
  • Softway MedicalcoreTechnology or Integration · 1 November 2022Softway Medical integrated Posos into its Hopital Manager hospital software — enabling prescription safety features for Softway's hospital customers in France.
  • DedalusflagshipTechnology or Integration · 1 May 2021SantExpo 2021 — A first in prescription assistance in hospitals with Dedalus and Posos. Dedalus is one of Europe's largest hospital software vendors; Posos is embedded in their hospital EHR suites.

Scale indicators16 records

Recent moves6 records

Expansion highlights7 records

Posos competitors and assessment

Company assessment

Direct peers

  • Wolters Kluwer Clinical Drug Information (Lexicomp/Medi-Span): Wolters Kluwer's Clinical Drug Information division offers Lexicomp and Medi-Span drug databases used by hospitals and EHRs for drug interaction, dosing, and clinical decision support. Direct peer to Posos' drug database and risk analysis API; larger and globally established with deeper hospital penetration.
  • First Databank (FDB): FDB (owned by Hearst) provides drug databases (FDB MedKnowledge) and clinical decision support embedded in major US EHRs. Direct competitor in the structured drug knowledge / API-for-software-editors space; primarily US-focused but increasingly global.
  • DrFirst: DrFirst offers medication management, e-prescribing, drug interaction checking, and clinical workflow APIs used by hospitals, EHRs, and pharmacies. Comparable to Posos' prescription safety and risk analysis APIs; US-based with similar B2B-to-software-editor GTM.
  • Corti: Corti builds the Agentic Framework for clinical AI workflows, launched February 2026, into which Posos was integrated as a drug/prescription Expert. Comparable AI-platform-for-clinicians offering with overlapping customer base (hospitals, telehealth), though focused on ambient conversation/intake rather than drug safety.

Broad incumbents

  • Elsevier Clinical Solutions (ClinicalKey/Gold Standard): Elsevier's Clinical Solutions includes drug databases (Gold Standard), ClinicalPath decision support, and ClinicalKey reference platform embedded across global hospital systems. Broad incumbent with overlapping drug database capabilities but a much wider portfolio beyond prescription safety.
  • Oracle Health (Cerner Multum): Oracle Health (formerly Cerner) bundles the Multum drug database and clinical decision support within its dominant EHR installed base. Massive global incumbent; competes with Posos at the hospital EHR layer and increasingly partners/competes via its own drug database.

Emerging players

  • Suki AI: Suki AI offers an AI voice assistant for clinicians that automates documentation, coding, and point-of-care queries including drug information. Emerging AI assistant for clinicians — partial overlap with Posos' individual practitioner product, though focused on ambient documentation rather than drug safety.
  • Nabla: Nabla is an AI ambient scribe and clinical assistant for physicians, expanding into broader clinical decision support. Partial overlap with Posos' individual clinician product; both target AI-augmented prescribing workflows but Nabla leads with documentation.
  • Abridge: Abridge is a medical conversation AI platform that structures patient-clinician dialogue into clinical notes, codes, and orders. Comparable AI-for-clinicians GTM with hospital system integrations; potential partner or competitor as it expands into order entry and prescription workflows.
  • Infermedica: Infermedica builds AI-powered symptom checking, triage, and preliminary diagnosis tools used by insurers, telehealth, and hospital systems. Adjacent clinical decision support category with API-first delivery; Europe-based (Poland) and comparable scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Posos social profiles

Digital presence

Posos compliance and trust

Trust signal

Compliance8 records

Posos financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Posos leadership team

Management profile

Number of profiles

Profiles2 records

Posos funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Posos M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Posos

What does Posos do?

Posos provides a CE IIb certified, ISO 13485 compliant AI medical platform that combines a drug knowledge graph, hybrid NLP and Computer Vision APIs for prescription transcription and clinical data structuring, and contextualized drug risk analysis. The platform is sold as a B2B API suite (FHIR, CDS Hooks, GraphQL) to medical software editors and as an enterprise solution to hospitals, with a freemium B2C mobile app for individual practitioners.

Is Posos a public or private company?

Posos is a private company. It is classified as venture growth investor backed and is currently operating.

When was Posos founded?

Posos was founded in 2020. It employs 51 to 100 people.

Where is Posos based?

Posos is headquartered in Paris, France, in the Europe region.

How does Posos make money?

Four revenue lines are on record. Freemium + Premium Subscription (B2C) is the primary driver. The others are B2B API & Software Licensing (Éditeurs de logiciels), enterprise Hospital Contracts and professional Services & Training.

Who are Posos's main competitors?

Direct peers on record are Wolters Kluwer Clinical Drug Information (Lexicomp/Medi-Span), First Databank (FDB), DrFirst and Corti. Broad incumbents are Elsevier Clinical Solutions (ClinicalKey/Gold Standard) and Oracle Health (Cerner Multum). Emerging players are Suki AI, Nabla, Abridge and Infermedica.

Does Posos have an API?

Yes. Posos offers certified CE class IIb APIs for medical software editors and AI developers. APIs include: (1) Intelligent prescription transcription API - upload photos of prescriptions and retrieve structured data (molecule, form, dose, modalities, frequency) in PN13, HL7, and FHIR formats; (2) Drug risk analysis API - personalized medication risk analysis taking into account multiple sources and full patient criteria (interactions, contraindications, therapeutic alternatives, dosage adaptation, indications, adverse effects, DDI Predictor cytochrome interactions, anticholinergic load, dose equivalence, crushability, renal/hepatic dosage); (3) Drug database API - access to a drug database 100% structured according to the SNOMED reference framework. Built on GraphQL for querying the knowledge graph. Modern FHIR and CDS Hooks native APIs. Includes proprietary AI models for retrieval and transcription of patient history. Sandbox available via demo request at https://www.posos.co/solutions/demo-api. Developer documentation is at www.posos.co/solutions/demo-api.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PososEtude pour mesurer l'impact des outils de détection et de correction de la iatrogénie aux urgencesA French study, led by Posos and involving the AP-HP and CHU Amiens-Picardie, is examining the medical and economic benefits of using AI tools to detect and correct iatrogenic risks in emergency departments. The study aims to reduce prescription errors, improve patient safety, and cut hospital costs over a 24-month period, with initial simulation phases and real-world testing.PososPosos et NEHS Digital unissent leurs forces pour offrir une gestion optimisée du temps aux anesthésistes et urgentistesPosos and NEHS Digital announced a partnership to integrate medication prescription management solutions into the OSOFT Electronic Health Record system used by hospitals in France. This integration aims to improve efficiency and safety for anesthesiologists and emergency physicians, especially in the context of healthcare staff shortages and increasing patient complexity.PososCorilus et Posos : un nouveau standard de prescriptionMedtech company Posos and healthcare software provider Corilus announced a strategic partnership to integrate Posos's AI-assisted prescription algorithms and drug database into Corilus's software platforms, starting with deployment in 2026 across CareConnect in Belgium and Softalmo in France. The tool will provide contextual therapeutic controls including drug interaction detection, cross-allergy alerts, contraindications, and pre-therapeutic test verification, targeting over 30,000 healthcare professionals using Corilus software across Europe. For Posos, the partnership represents a significant step in international expansion, while Corilus gains what it describes as essential infrastructure for scaling AI-powered clinical assistance solutions.PososLe Centre Hospitalier de la Côte Basque choisit Posos, intégré au dossier patient informatisé InterSystems TrakCare, pour renforcer la sécurisation du circuit de prescriptionLe Centre Hospitalier de la Côte Basque a choisi d'intégrer la solution Posos à son dossier patient informatisé TrakCare pour améliorer la sécurisation et la rapidité du circuit de prescription médicamenteuse. La plateforme permet d'automatiser la saisie des traitements, d’analyser les risques médicamenteux personnalisés et de faciliter la conciliation médicamenteuse, ce qui réduit le temps de traitement administratif et augmente la sécurité des soins.PososEvolucare et Posos concluent un partenariat pour simplifier le travail des anesthésistesEvolucare, a healthcare software provider, and Posos, a therapeutic recommendation solution, announced a strategic partnership aimed at simplifying prescription entry for anesthesiologists. The partnership enables clinicians to import treatment plans by scanning prescriptions or PDF files, significantly reducing transcription time and errors.PososLe CHI Fréjus-Saint-Raphaël s’équipe de Posos pour améliorer la qualité de vie au travail de son personnel médicalThe Centre Hospitalier Intercommunal de Fréjus-Saint-Raphaël has deployed Posos, an AI-powered therapeutic recommendation tool, for its anesthesiologists starting early May. The solution enables practitioners to photograph handwritten prescriptions and instantly transcribe them into the hospital's medical software (Diane by BOW MEDICAL), saving up to 5 minutes per patient consultation while reducing transcription errors. The partnership integrates Posos with BOW MEDICAL's Diane system through the FHIR interoperability standard to improve patient safety and working conditions for medical staff.PososComment réaliser efficacement un bilan partagé de médication ?This article is an informational guide explaining the shared medication review (bilan partagé de médication) process in France for polymedicated elderly patients over 65, describing its five-step implementation process from initial patient interview to final review. It highlights key challenges pharmacists face, including the time burden (over three hours per review for a 60-euro compensation) and information aggregation difficulties, while presenting Posos as an automated solution that can transcribe prescriptions from photos, analyze adherence, and evaluate anticholinergic load. The article emphasizes that medication-related hospitalizations in France have increased by 136% over 10 years, underscoring the importance of such pharmaceutical support services in reducing medication-related harm.PososL'URPS Pharmaciens a retenu Posos pour faciliter la prévention de la iatrogénie médicamenteuseURPS Pharmaciens Hauts-de-France, in partnership with URPS Médecins Libéraux Hauts-de-France and with support from ARS Hauts-de-France, has selected Posos via a call for tenders conducted by GRADeS Inéa for the OPTIMED project aimed at preventing medication-related risks in elderly patients. The digital solution developed by Posos, a medtech company specializing in AI-assisted medication prescription, facilitates collaboration between doctors and pharmacists through Shared Medication Reviews (BPM) on a dedicated platform. Deployed since July 2024 across the Hauts-de-France region, the initiative addresses polymedication risks, which French health authorities estimate account for 44% of serious care-related events.PososGiropharm s’associe à Posos pour accompagner ses pharmaciens adhérents dans la réalisation de leurs nouvelles missions.Giropharm, a French cooperative group of 1,800 independent pharmacies, has partnered with Posos, a medtech specializing in AI-assisted prescriptions, to enhance pharmacists' ability to perform shared medication reviews (BPM). This collaboration aims to optimize medication management and improve patient safety, addressing the significant challenge of polypharmacy among elderly patients.PososPosos lance la première base de données des médicaments qui s’affranchit de la barrière de la langueMedtech company Posos announced the launch of its proprietary medication database, Posos Medical Data Base, after three years of development using AI-powered natural language processing and editorial work from over 50 pharmacists and physicians.